Treatment of ocular rosacea: a systematic review

J Dtsch Dermatol Ges. 2024 Feb;22(2):167-174. doi: 10.1111/ddg.15290. Epub 2024 Jan 20.

Abstract

Rosacea is a common chronic skin disease distributed primarily around the central face. Ocular manifestations of rosacea are poorly studied, and estimates of prevalence vary widely, ranging from 6% to 72% in the rosacea population. Treatment options for ocular rosacea include lid hygiene, topical and oral antibiotics, cyclosporine ophthalmic emulsion, oral vitamin A derivatives, and intense pulsed light; however, a direct comparison of treatment methods for ocular rosacea is lacking. This review aims to compare treatment efficacy and adverse events for different treatment modalities in ocular rosacea. We performed a systematic review by searching Cochrane, MEDLINE and Embase. Title, abstract, full text screening, and data extraction were done in duplicate. Sixty-six articles met the inclusion criteria, representing a total of 1,275 patients. The most effective treatment modalities were topical antimicrobials and oral antibiotics, which achieved complete or partial response in 91% (n = 82/90) and 89% (n = 525/580) of patients respectively, followed by intense pulsed light (89%, n = 97/109 partial response), cyclosporine ophthalmic emulsion (87% n = 40/46), and lid hygiene (65%, n = 67/105). Combination treatments achieved a complete or partial response in 90% (n = 69/77). Results suggest that topical antimicrobials, oral antibiotics, intense pulsed light. and cyclosporine were the most efficacious single modality treatments.

Keywords: IPL; Rosacea; adverse events; doxycycline; isotretinoin; ocular; treatment.

Publication types

  • Systematic Review
  • Review

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Cyclosporine / therapeutic use
  • Emulsions
  • Humans
  • Rosacea* / diagnosis
  • Rosacea* / drug therapy
  • Skin Diseases* / drug therapy

Substances

  • Emulsions
  • Anti-Bacterial Agents
  • Cyclosporine